Graboyes Marc H 4
4 · ALLOS THERAPEUTICS INC · Filed Apr 14, 2010
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Sale
Common Stock
2010-04-12$8.58/sh−75,000$643,530→ 57,912 total - Exercise/Conversion
Common Stock
2010-04-12$2.70/sh+75,000$202,500→ 132,912 total - Exercise/Conversion
Stock Options (Right to Buy)
2010-04-12−75,000→ 0 totalExercise: $2.70From: 2007-02-10Exp: 2016-02-10→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Graboyes sold a portion of his holdings for tax and estate planning purposes.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $8.53 to $8.60. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the date of grant and an additional one forty-eighths (1/48) of the total number of shares subject to the option shall vest each one month period thereafter, until all such shares are vested and exercisable.